Retrospective comparison of thyroid and whole-body residence time of radioiodine in patients with differentiated thyroid carcinoma at initial ablative radioiodine therapy and follow-up whole-body scintigraphy after a short period of hypothyroidism or under rhTSH stimulation

被引：0

作者：

Bacher, R. ^{[1
]}

Dietlein, M. ^{[1
]}

Kobe, C. ^{[1
]}

Hohberg, M. ^{[1
]}

Wild, M. ^{[1
]}

Drzezga, A. ^{[1
]}

Schmidt, M. ^{[1
]}

机构：

[1] Univ Hosp Cologne, Cologne, Germany

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2018年 / 45卷

关键词：

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

EP-0763

引用

页码：S606 / S607

页数：2

共 50 条

[31] Impact of Radioiodine Therapy in Thyroid Differenciated Carcinoma Patients with Increased Thyroglobulin Level and Negative 131I Whole-Body Scan after Ablation
Bota, E. C.
Lopes, F. G.
Santos, J. A. M.
Soares, O.
Bastos, A. L.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S111 - S111
[32] Exogenous or endogenous TSH stimulation before radioiodine therapy of metastatic thyroid cancer patients? The answer from post-therapy whole-body scan
Pires, L. M. P.
Costa, G.
Albuquerque, A.
Pedroso de Lima, J.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S504 - S504
[33] Diagnostic Value of Recombinant Human Thyrotropin-Stimulated 123I Whole-Body Scintigraphy in the Follow-Up of Patients With Differentiated Thyroid Cancer
Alzahrani, Ali S.
AlShaikh, OmAlkhaire
Tuli, Mahmoud
Al-Sugair, Abdulaziz
Alamawi, Reem
Al-Rasheed, Maha M.
CLINICAL NUCLEAR MEDICINE, 2012, 37 (03) : 229 - 234
[34] Diagnostic 131-Iodine whole-body scan still has a role in follow up of differentiated thyroid carcinoma
Sayed, Mohamed
JOURNAL OF NUCLEAR MEDICINE, 2012, 53
[35] Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer
Markus Dietlein
Klemens Scheidhauer
Eberhard Voth
Peter Theissen
Harald Schicha
European Journal of Nuclear Medicine, 1997, 24 : 1342 - 1348
[36] Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer
Dietlein, M
Scheidhauer, K
Voth, E
Theissen, P
Schicha, H
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1997, 24 (11) : 1342 - 1348
[37] CAN I-131 WHOLE-BODY SCAN BE REPLACED BY THYROGLOBULIN MEASUREMENT IN THE POSTSURGICAL FOLLOW-UP OF DIFFERENTIATED THYROID-CARCINOMA
RONGA, G
FIORENTINO, A
PASERIO, E
SIGNORE, A
TODINO, V
TUMMARELLO, MA
FILESI, M
BASCHIERI, I
JOURNAL OF NUCLEAR MEDICINE, 1990, 31 (11) : 1766 - 1771
[38] CAN I-131 WHOLE-BODY SCAN BE REPLACED BY THYROGLOBULIN MEASUREMENT IN THE POSTSURGICAL FOLLOW-UP OF DIFFERENTIATED THYROID-CARCINOMA
SCHLUMBERGER, M
JOURNAL OF NUCLEAR MEDICINE, 1992, 33 (01) : 172 - 173
[39] 99mTc-Sestamibi and 131I whole-body scintigraphy and initial serum thyroglobulin in the management of differentiated thyroid carcinoma
Ng, DCE
Sundram, FX
Sin, AE
JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (04) : 631 - 635
[40] Value of Thyroglobuline (Tg) measurements and Iodine-131 whole body scintigraphy (I131-WB) after rhTSH stimulation in patients with Differentiated Thyroid Carcinoma (DTC)-10 years of follow-up
Carvalho, H.
Ferreira, T.
Limbert, E.
Salgado, L.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S351 - S351

← 1 2 3 4 5 →